Nisha Acharya MD

Uveitis

Professor, Department of Ophthalmology and Epidemiology Director of Uveitis Service, Proctor Foundation University of California San Francisco

Join to view full profile

95 Kirkham StSan Francisco, CA 94122
Phone+1 415-476-1442

Dr. Acharya is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Acharya's full profile Already have an account?

Education & Training

University of California (San Francisco)Fellowship, Cornea, External Diseases, and Refractive Surgery, 2004 - 2006
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 2001 - 2004
Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2000 - 2001
University of California San Francisco School of MedicineClass of 2000

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2004 - 2027
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2017

Clinical Trials

Steroids for Corneal Ulcers Trial
COMPLETED
PHASE4
Lucentis for Inflammatory Macular Edema Trial
COMPLETED
PHASE1, PHASE2
Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer
COMPLETED
PHASE1, PHASE2

Publications & Presentations

PubMed

Quantitative Analysis of Retinal Fluid by a Deep Learning Model in Uveitic Macular Edema.
Anthony Wu, Adrian Au, Justin Hanson, Marcus Yamamoto, Joy Cheng
Ophthalmology Science. 2026-08-01
The Effects of a Digital Mindfulness Intervention on Mental Health and Vision-Related Quality of Life in Noninfectious Uveitis.
Jessica G Shantha, Isabel Ray, Anika Kumar, Daisy Yan, Kirsten Da Silva
Ophthalmology. 2026-06-15
Integrated metagenomic sequencing and phage display-based immunoprecipitation sequencing for presumptive viral infection: a case report.
Jessica G Shantha, Cindi Chen, Armin Hinterwirth, John A Gonzales, Nisha R Acharya
American Journal of Ophthalmology Case Reports. 2026-06-01

Press Mentions

Attacks on Federal Science Hit Bay Area Researchers Studying Vaccines: ‘I Have to Let People Go’March 30th, 2025
Her Research Revealed a Safety Concern with a Vaccine. Then the NIH Pulled Her FundingMarch 28th, 2025
Adalimumab: To Stop or Not to Stop for Juvenile Idiopathic Arthritis–Associated Uveitis?January 30th, 2025

Grant Support

Adalimumab Dose Adjustment for Pediatric uveitis Treatment (ADAPT) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2026–2030
The Impact of the Herpes Zoster Vaccine on Herpes Zoster OphthalmicusUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2028
Programmable Phage Display Peptidomes to Characterize UveitisUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2026
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2025